| Literature DB >> 29962920 |
Laurene Boateng1, Irene Ashley2, Agartha Ohemeng1, Matilda Asante2, Matilda Steiner-Asiedu1.
Abstract
Vitamin A deficiency (VAD) remains a major public health issue and is reported to be the cause of about 6 percent of child deaths under the age of 5 years in Africa. Inadequate dietary intake of vitamin A-rich foods is a major cause of VAD. Moringa oleifera leaf powder (MLP) is rich in nutrients particularly vitamin A and its use in infant feeding has been explored. This pilot study was designed to test the efficacy of MLP in improving blood retinol concentrations among infants in a rural district in Ghana. A subset of infants participating in a randomized controlled trial (ISRCTN14377902) were randomly assigned to receive one of the three study foods (MCL-35g and MS-5g both of which were fortified with MLP, and a third food, CF-35g, a cereal legume blend which served as the control food) in a feeding intervention that lasted for 6 weeks. Primary outcome of the pilot study was retinol levels measured in 5 ml of whole blood at baseline and endline using the iCheck™ Fluoro device. A total of 103 infant-mother pairs were recruited at baseline, of which 65 completed the study. All the infants in the study were vitamin A deficient at both baseline and endline when compared to the World Health Organization (WHO) threshold of 0.70µmol/l. There was however a marginal non-significant increase in blood vitamin A concentrations for all three groups at endline, with higher numerical increases seen in the two Moringa supplemented groups. VAD is a significant public health problem and MLP could be an affordable and sustainable means of combatting the issue. The efficacy of MLP in improving vitamin A status of infants however needs to be ascertained in well-designed trials involving larger numbers of infants and which will last for longer periods. Such studies will also be beneficial in helping to establish the long-term acceptability of complementary foods that incorporate MLP in the target population.Entities:
Keywords: Moringa oleifera leaf powder; Vitamin A deficiency; infants and young children
Mesh:
Substances:
Year: 2018 PMID: 29962920 PMCID: PMC6020727
Source DB: PubMed Journal: Yale J Biol Med ISSN: 0044-0086
Contribution of fresh and dried Moringa oleifera leaves to the nutrient needs of children aged 1-3 years. Source: Adapted from Witt [6]. Used with permission.
| 15.2kcal, 0.064MJ | 17.3kcal, 0.072MJ | 1098kcal, 4.6MJ | 1 | 2 | |
| 1.2 | 1.76 | 13 | 9 | 14 | |
| 2.0 | 1.3 | 19 | 11 | 7 | |
| 95 | 106 | 700 | 14 | 15 | |
| 23.65 | 5.2-30.2 | 80 | 29 | 6.5-38 | |
| 1.625 | 2.16 | 7(14) | 23(12) | 31(15) | |
| 0.12 | 0.06-0.26 | 3(6) | 4(2) | 2(1) | |
| 0.13 | 0.05 | 0.5 | 26 | 9 | |
| 0.06-1.0 | 0.15 | 0.5 | 12-200 | 29 | |
| 0.41 | 0.74 | 6 | 7 | 12 | |
| 0.12 | 0.24 | 0.5 | 24 | 48 | |
| 27 | 41 | 150 | 18 | 27 | |
| 182 | 258 | 300 | 61 | 86 | |
| 8.6 | 32.4 | 15 | 57 | 216 | |
| 2.8-5.6 | 5 | 6 | 46-93 | 83 | |
Nutrient content of study foods.
| 35 | 5 | 35 | |
| 144.64 | 10.25 | 142.15 | |
| 6.40 | 1.38 | 5.88 | |
| 3.78 | 1.13 | 2.53 | |
| 51.95 | 24.82 | 0.27 |
CF-35g- control, MCL-35g – Moringa with Weanimix, MS-5g – Moringa as Sprinkles
Figure 1Flow of infants through the study.
Background characteristics of study participants at baseline.
| 62.90 | 58.80 | 73.50 | 0.42 | |
| 9.0±1.30 | 9.1±1.40 | 9.3±1.40 | 0.48 | |
| 68.11±2.84 | 68.51±2.78 | 68.00±11.45 | 0.59 | |
| 7.98±1.07 | 7.87±0.97 | 8.89±6.31 | 0.38 | |
| -0.89 ± 1.17 | -0.85 ± 1.04 | -1.2 ±1 .10 | 0.21 | |
| -0.57 ± 1.18 | -0.6 ± 1.22 | -0.9 ± 1.10 | 0.88 | |
| -0.1 ± 1.13 | -0.3 ± 1.17 | -0.3 ± 1.00 | 0.71 | |
| 10.40 ± 1.13 | 10.36 ± 1.36 | 10.17±1.29 | 0.73 | |
| 2.71±2.15 | 3.09 ±2.07 | 2.88±1.90 | 0.34 | |
| 26.77±9.34 | 27.68±7.66 | 25.82±6.45 | 0.63 | |
| 82.90 | 91.20 | 73.50 | 0.73 | |
| 6.80±2.41 | 6.32±3.23 | 6.18±2.36 | 0.60 | |
| 74.30 | 44.10 | 35.30 | 0.04 | |
| 5.70 | 20.60 | 8.80 | 0.13 | |
| 28.60 | 11.8.0 | 26.50 | 0.19 | |
| 28.60 | 29.40 | 32.40 | 0.94 | |
| 45.70 | 26.50 | 50.00 | 0.11 | |
| 40.00 | 38.20 | 50.00 | 0.33 |
CF-35g- control, MCL-35g – Moringa with Weanimix, MS-5g – Moringa as Sprinkles
Baseline and end line energy and nutrient intakes of study infants by group.
| 356.945±244.11 | 426.92±249.29 | 448.875±253.18 | |
| 570.3±324.33 | 554.945±221.70 | 598.28±399.51 | |
| 11.965±16.99 | 11.27±7.29 | 11.625±7.27 | |
| 15.38±8.91 | 18.88±8.96 | 17.28±10.75 | |
| 73.705±111.32 | 73.81±36.71 | 70.74±42.52 | |
| 94.375±56.67 | 82.76±32.45 | 95.48±71.99 | |
| 10.575±10.93 | 14.71±14.75 | 9.827±10.83 | |
| 16.345±14.42 | 17.54±10.68 | 32.865±59.51 | |
| 5.075±4.47* | 8.78±4.56* | 6.135±3.87* | |
| 8.43±5.82 | 11.456±6.58 | 9.145±7.36 | |
| 280.87±635.73 | 703.035±809.99 | 632.335±715.66 | |
| 642.38±944.29 | 634.025±619.59 | 896.98±770.69 |
CF-35g- control, MCL-35g – Moringa with Weanimix, MS-5g – Moringa as Sprinkles. Values are reported as means and standard deviations.*Significant at p = 0.026.
Serum vitamin A concentrations at baseline and end line for infants who completed the study.
| 0.45±0.16 | 0.55±0.16 | 0.09 | |
| 0.52±0.18 | 0.63±0.38 | 0.14 | |
| 0.57±0.20 | 0.65±0.20 | 0.82 | |
CF-35g- control, MCL-35g – Moringa with Weanimix, MS-5g – Moringa as Sprinkles
Comparison of serum vitamin A at endline for infants who completed the study.
| 0.55 ± 0.16 | 0.63 ± 0.38 | 0.65 ± 0.32 | 0.83 |
CF-35g- control, MCL-35g – Moringa with Weanimix, MS-5g – Moringa as Sprinkles; 1Data are mean ± standard deviation;2P values compare all 3 groups using analysis of covariance (ANCOVA), with adjustment for infant age, sex and baseline hemoglobin and serum vitamin A levels. Significance was set at p ≤ 0.05
Figure 2Adherence of infants to study foods over the study period.
Morbidity occurrence among infants during the study.
| 8.6 | 8.8 | 8.8 | |
| 22.9 | 8.8 | 26.5 | |
| 22.9 | 38.2 | 11.8 | |
| 28.6 | 50 | 8.8 | |
| 28.6 | 44.1 | 32.4 |
CF-35g- control, MCL-35g – Moringa with Weanimix, MS-5g – Moringa as Sprinkles